Mythic has $103M to solve ADC mysteries
To view this email as a web page, click here

Today's Rundown

Featured Story

Valneva, Arcturus add to bombardment of booster boasting for COVID-19 shots

It’s the battle of the boosters. A day after Sanofi and GlaxoSmithKline said their COVID-19 shot works well as a booster for other shot regimens, Valneva and Arcturus Therapeutics are adding to the chorus.

read more

Top Stories

ALS drug discoverer Verge signs on Merck, Lilly for nearly $100M oversubscribed funding round

Eli Lilly and Merck are piling on to fund AI drug discovery company Verge Genomics, which has a fresh $98 million to continue its tech-enabled approach to finding new medicines.

read more

Mystery no more: Mythic Therapeutics emerges with $103M to test antibody-drug conjugates in lung cancer

Mythic Therapeutics emerged with a $103 million series B to bankroll trials of its antibody-drug conjugates, which the small biotech claims are safer and smarter than previously developed treatments in the drug class.

read more

Sponsored: 7 Applications for Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Specimens

As technologies and methodologies advance, so do the potential applications for biospecimens. In this article, we explore seven uses of FFPE, ranging from the common to the cutting-edge.

read more

Up to $1.5B on the Horizon for Alpine in four drug biobucks pact

Horizon Therapeutics will dole out up to $1.5 billion in milestone payments to bring up to four Alpine drugs from the horizon all the way to the top of the Alps.

read more

Neogene adds ex-Roche director as CMO after snagging Bristol Myers, Arcellx vets

After snagging a 19-year Bristol Myers Squibb veteran in May and an Arcellx executive this fall, Neogene Therapeutics strikes again by poaching Gritstone Chief Medical Officer Raphaël Rousseau.

read more

NuVasive resumes global sales of scoliosis system with reinstated CE mark and new labeling

The stars are aligning for NuVasive and its MAGEC spine-straightening system.

read more

Biogen hits the gas pedal on Aduhelm confirmatory trial, hoping to deliver results in 2026

Biogen is looking to get initial data from the FDA-mandated confirmatory trial for its Alzheimer’s disease drug Aduhelm out in four years, as the fate of this drug, and Biogen itself, rests in the balance.

read more

Moody's: Outlook stable for insurers in 2022, but COVID-19's effects could linger

The outlook for insurers is stable heading into 2022, particularly as the ongoing impacts of COVID-19 recede, according to a new report from Moody's Investors Service.

read more

Resources

Whitepaper: Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial

Sites receiving augmentation support enroll more than 30,000 patients in just over three months. See how additional site resources can make a difference.

Whitepaper: Patients Want Choice Offered through Hybrid Clinical Trials

New survey results and insights help clinical trial sponsors improve diversity and inclusion, enroll faster, and keep participants engaged longer.

Whitepaper: Healthcare Technical Due Diligence: Assessing a New Cancer Treatment

A major Korean biopharmaceutical company wanted to gather unbiased opinions on a new cancer treatment product. Fill out our form to learn more.

Whitepaper: Demand Planning for New Drug/Device Combination

Download now to learn how GLG helped a biotech company plan for the demand of a new drug/device combination by commissioning a forecasting study.

Whitepaper: QC for ex vivo manipulated cell lines and tissues

A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.

Research: How Buffer Prep Services Alleviate Sudden Spikes in Campaign Volume

Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific

Whitepaper: Modernizing Key Clinical Trial Processes with Artificial Intelligence

This whitepaper addresses where AI can make the biggest impact in clinical trials. The stakes are too high for patients to leave decision-making to machines, but AI can lend administrative support that empowers staff and medical experts alike to carry out their jobs more effectively.

Whitepaper: Medable was able to cut costs in multiple clinical trials by over US$25,000,000

Find out how to improve clinical protocol adherence, and thus patient outcomes, by 15%+ with Medable’s latest White Paper.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

2021 Report: Clinical Trial Management in a Post-Pandemic World

New market research provides valuable insight into the impact of adaptations made in clinical trials during the pandemic.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Events